Thus, it is possible that triple reactive antibodies—targeting DNase1L3, dsDNA and cardiolipin—may contribute to the pool of anti-phospholipid antibodies in SLE. The gene discussed is DNASE1L3; the disease is systemic lupus erythematosus.